17 alpha-hydroxyprogesterone caproate has been researched along with diethylstilbestrol in 2 studies
Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (diethylstilbestrol) | Trials (diethylstilbestrol) | Recent Studies (post-2010) (diethylstilbestrol) |
---|---|---|---|---|---|
517 | 88 | 251 | 8,585 | 322 | 491 |
Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | diethylstilbestrol (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 12.5893 | |
Estrogen receptor | Homo sapiens (human) | 0.1312 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.67 | |
Adenosine receptor A3 | Homo sapiens (human) | 2.208 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.963 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
Substance-K receptor | Homo sapiens (human) | 9.553 | |
D(1A) dopamine receptor | Homo sapiens (human) | 7.763 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 5.6 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.67 | |
Thromboxane-A synthase | Homo sapiens (human) | 4.359 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 4.79 | |
Adenosine receptor A2a | Homo sapiens (human) | 9.013 | |
Adenosine receptor A1 | Homo sapiens (human) | 2.856 | |
Mu-type opioid receptor | Homo sapiens (human) | 5.778 | |
D(3) dopamine receptor | Homo sapiens (human) | 8.796 | |
Delta-type opioid receptor | Homo sapiens (human) | 2.718 | |
Kappa-type opioid receptor | Homo sapiens (human) | 4.563 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.14 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.071 | |
Aldehyde oxidase | Homo sapiens (human) | 0.46 | |
Estrogen receptor beta | Homo sapiens (human) | 0.1588 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lopez, J; Ogren, L; Talamantes, F; Verjan, R | 1 |
CROWLEY, LG; MACDONALD, I | 1 |
2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and diethylstilbestrol
Article | Year |
---|---|
Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in mice.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Aging; Animals; Animals, Newborn; Diethylstilbestrol; Estrogen Antagonists; Female; Hydroxyprogesterones; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H | 1988 |
DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Breast Neoplasms; Diethylstilbestrol; Drug Therapy; Estradiol; Estrogens; Female; Geriatrics; Humans; Hydroxyprogesterones; Menopause; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Pathology; Postmenopause | 1965 |